- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Virtual Event – The Impact of 2nd Generation Antipsychotic Side Effects on Functioning from a Schizophrenia Patient Perspective: A Global Patient Centered Study
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – The Impact of 2nd Generation Antipsychotic Side Effects on Functioning from a Schizophrenia Patient Perspective: A Global Patient Centered Study
This is a Virtual Event for PsychU members in San Diego, Inland Empire, Nevada and Idaho.
In this presentation, the objective is to:
- Understand how specific side effects impact daily functioning,
- Emotional well-being, and
- Overall quality of life (QoL) of patients with schizophrenia from their own perspective.
Featuring
-
Sucharita Somkuwar, PhD, BPharm (OPDC)
Clinical & Scientific Liaison
Speaker Sucharita Somkuwar, PhD, BPharm is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
Registration
Related Resources
-
Practical Application of Wellness Strategies for Individuals in Underserved Communities with Major Depressive Disorder (MDD) & Post-Traumatic Stress Disorder (PTSD)
On-Demand Webinar July 12, 2024Approximately 50 million United States adults are living with a mental illness, with 21 million having depression and 13 million with post-traumatic stress disorder.1-4 Minority individuals are among these prevalence…
-
Talking Points (Part I): Primary Care on PTSD – David Lewis
Podcast July 10, 2024Listen to Amica Simmons-Yon, PharmD, PhD as she spills the tea on a new Talking Points Series from Primary Care on Post-Traumatic Stress Disorder (PTSD) with special guest, David E….
-
Primary Care PTSD Screen For DSM-5 (PC-PTSD-5)
Downloadable Resource June 27, 2024The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) is a 5-item screen designed to identify individuals with probable PTSD in primary care settings. The measure begins with an item which assesses lifetime…
Event Navigation
- « Virtual Event – The Impact of 2nd Generation Antipsychotic Side Effects on Functioning from a Schizophrenia Patient Perspective: A Global Patient Centered Study
- Long-Acting Injectable Antipsychotics & The Evolving Healthcare Landscape Post-COVID-19 Pandemic For Patients With Schizophrenia & Bipolar I Disorder »
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: